IndiTreat®. Be the Change.

IndiTreat® is changing the way decisions are made for mCRC patients.

By resolving the blind spots in traditional methods such as biomarker testing, functional drug sensitivity testing now offers personalised treatment decisions for all patients. Join us. Make the best possible decision for all your patients. Be the Change.

Decisive innovation in mCRC

Functional drug sensitivity tests resolve blind spots where biomarkers are lacking.

Use IndiTreat® immediately. CE IVD-marked, the test can be employed straight away in clinical settings.

Be assured of the highest quality. The organoids used in IndiTreat® are the best model of your patient's original tumor.

IndiTreat Start®

Sequence matters - get the best possible start to maximize patient benefit

IndiTreat Extend®

Extend therapy decision-making boundaries for third- and further-line mCRC patients

IndiTreat Explore®

Explore additional options for third- and further-line mCRC patients

Stay updated with our news and press releases

Get notified by mail when news or press releases are published on our website.

Functional drug sensitivity tests resolve blind spots where biomarkers are lacking.

Use IndiTreat® immediately. CE IVD-marked, the test can be employed straight away in clinical settings.

Be assured of the highest quality. The organoids used in IndiTreat® are the best model of your patient's original tumor.

A paradigm shift in CRC treatment

Functional drug sensitivity testing is changing the way decisions are made when selecting chemotherapy for mCRC patients. In this article, Medical Director Raphael Gruber discusses why and how this paradigm shift perfectly complements biomarker testing and its blind spots.

IndiTreat® Brochure

IndiTreat® is changing the way in which treatment decisions are made for mCRC patients. For more detailed information about functional drug sensitivity testing and IndiTreat®, please take a look at our online brochure.

Go to brochure

Medical Digests

fDST is on the upswing! Check here regularly for our take on things and benefit from quick and to-the-point Medical Digests.

IndiTreat® Brochure

IndiTreat® is changing the way in which treatment decisions are made for mCRC patients. For more detailed information about functional drug sensitivity testing and IndiTreat®, please take a look at our online brochure.

2cureX Newsroom

IndiTreat® is a 2cureX product. For the latest news and press releases related to 2cureX, please visit our Newsroom.